ESC 365
ESC 365
Sign in

    Back

    Benefits and risks of antithrombotic therapy in diabetes.

    2 September 2019 (15:12 - 15:26)
    Organised by:
    Congress Presentation Part of: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD) Lipids Open Access ESC Congress 2019

    Video

    Sign in to view the resources

    Slides

    Sign in to view the resources

    About the speaker

    Photo
    Professor Bianca Rocca

    LUM University, Casamassima (Italy)

    4 More presentations in this session

    Presentation thumbnail
    What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases
    Professor F. Cosentino (Stockholm, SE)
    Slides Video
    Presentation thumbnail
    Management of dyslipidaemias.
    Doctor M. Lettino (Monza, IT)
    Slides Video
    Presentation thumbnail
    New evidence from cardiovascular outcome trials.
    Professor N. Marx (Aachen, DE)
    Slides Video
    Presentation thumbnail
    Glucose-lowering drugs and heart failure.
    Professor P. Seferovic (Belgrade, RS)
    Slides Video

    Access the full session

    Session thumbnail
    2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)

    The Event

    Event poster

    ESC Congress 2019

    2 September 2019 15:12 CET
    You may be interested in
    thumbnail
    Webinar
    Unmet needs in lipid management: treatment goals and how to achieve them
    Logo
    thumbnail
    Webinar
    Risk assessment and lipid management in primary prevention
    Logo
    thumbnail
    Congress Presentation
    State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia
    Logo